Drug Type Small molecule drug |
Synonyms ZLY032 |
Target |
Mechanism GPR40 agonists(Free fatty acid receptor 1 agonists), PPARδ agonists(Peroxisome proliferator-activated receptor delta agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H18F3NO4S |
InChIKeyYBBZJHLFUPKHJD-CQSZACIVSA-N |
CAS Registry2314465-67-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis, Liver | Preclinical | CN | 01 Sep 2020 |